Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study of BPN14770 in Adult Males With Fragile X Syndrome
Conditions
Interventions
BPN14770
Placebo
Locations
1
United States
Rush University Medical Center
Chicago, Illinois, United States
Start Date
July 9, 2018
Primary Completion Date
July 31, 2020
Completion Date
July 31, 2020
Last Updated
December 19, 2024
NCT06560242
NCT06139172
NCT05418049
NCT07439510
NCT06957054
NCT06261502
Lead Sponsor
Tetra Discovery Partners
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions